Stockscreener 앱 받기
14.93
2.26%
0.33
시장 영업 전:
14.98
0.05
+0.33%
Schrodinger Inc 주식(SDGR)의 최신 뉴스
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates - MSN
SDGR Q1 2026 Earnings: EPS Misses Estimates as Company Focuses on Pipeline ProgressEarnings Acceleration Picks - The League of Women Voters of Texas
Schrödinger Finalizes Transition Terms for Former Commercial Chief - The Globe and Mail
Schrodinger finalizes separation agreement with former chief commercial officer - Investing.com
Schrodinger separation of Mannix Aklian as Chief Commercial Officer confirmed - TradingView
Severance package for ex-commercial chief at Schrödinger (NASDAQ: SDGR) - Stock Titan
(SDGR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Schrödinger’s Call Review: The Power of a Final Call - DualShockers
10 Top Tech Companies in Munich - Built In
Recursion vs. Schrodinger: Comparing Biotech and Software Drug Discovery Strategies in 2026News and Statistics - IndexBox
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Does Schrödinger (SDGR) Changing Its CCO While Reaffirming Guidance Recast Its Commercial Playbook? - simplywall.st
Schrodinger Inc stock (US80655G1067): shares extend late-May rebound on Nasdaq - AD HOC NEWS
Schrödinger, Inc. Hits Day High with Strong 7.34% Intraday Surge - MarketsMojo
Schrödinger, Inc. Hits Day High with Strong Intraday Performance, Up 7.39% - Markets Mojo
Companies Like Schrödinger (NASDAQ:SDGR) Are In A Position To Invest In Growth - Moomoo
Another Indie Matched Mina The Hollower's Review Scores This Week And No One Noticed - TheGamer
A Look at Schrodinger Inc (SDGR) After 6.9% Gain -- GF Value $26 - GuruFocus
SDGR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Schrodinger Inc stock (US80655G1067): shares steady after May gains on Nasdaq - AD HOC NEWS
Schrödinger slides after early-stage trial data for cancer therapy - MSN
(SDGR) Risk Channels and Responsive Allocation - Stock Traders Daily
How The Schrödinger (SDGR) Investment Story Is Shifting As Analysts Reset Price Targets - Yahoo Finance
Stephens Investment Management Group LLC's Schrodinger Inc(SDGR) Holding History - GuruFocus
Schrodinger (SDGR) Issues Stock Options and RSUs to New Employees - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - pharmiweb.com
Schrodinger reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Schrodinger Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Schrödinger Announces Leadership Change Amid Maintained 2026 Outlook - TipRanks
Schrödinger, Inc. Reaffirms Earnings Guidance for the Second Quarter Ending June 30, 2026 and Fiscal Year Ending December 31, 2026 - marketscreener.com
Leadership change at Schrödinger (NASDAQ: SDGR) as CCO departs and outlook held - Stock Titan
My Top 3 Biotech Stocks for May 2026 - Yahoo Finance
Schrödinger Balances Growth and Losses in Earnings Call - TipRanks
SDGR: Improved funding and tech adoption are accelerating drug discovery and portfolio growth - TradingView
Schrodinger Inc at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Schrodinger : SDGR - 24/7 Wall St.
Cheminformatics Market Size, Share | Growth Forecast [2034] - Fortune Business Insights
Schrodinger stock (US80655G1067): AI-powered drug discovery story after latest earnings - AD HOC NEWS
Rubric Capital and David Rosen disclose 9.28% position in Schrodinger (SDGR) - Stock Titan
(SDGR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
SDGR Maintained by Morgan Stanley -- Price Target Lowered to $17 - GuruFocus
Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Cuts Target Price to $17 - Moomoo
Morgan Stanley Lowers Price Target on Schrodinger to $17 From $19, Keeps Equalweight Rating - marketscreener.com
Schrodinger, Inc. Stock 12‑Month Price Target Cut to $20.88, Implies 64% Upside - TradingView
SDGR: Hosted revenue jumps to 34% as broad-based growth and new products drive positive momentum - TradingView
SDGR Stock Price, Quote & Chart | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
Evogene to Present at the 24th Schrödinger European User Group Meeting - PR Newswire
TradingKey - TradingKey
UBS Group AG Buys 489,059 Shares of Schrodinger, Inc. $SDGR - MarketBeat
Number of shareholders of Schrodinger, Inc. – LS:A2PY7M - TradingView
Schrodinger Inc stock (US80655G1067): Q1 loss and revenue miss weigh on shares - AD HOC NEWS
Analysts Have Lowered Expectations For Schrödinger, Inc. (NASDAQ:SDGR) After Its Latest Results - simplywall.st
Earnings Update: Schrödinger, Inc. (NASDAQ:SDGR) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
2.22%
0.92%
자본화:
|
볼륨(24시간):